Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X:
“Cancer trial participation not associated with longer OS compared to routine care.
Motivation for patients:
- Potential benefits other than OS eg structured care protocols.
- To contribute to a better treatment for FUTURE patients.”
Additional information.
Source: Matthias Guckenberger/X